Atlas Trials

Liver Toxicity in Lung Cancer Patients Treated With Immune-checkpoint Inhibitors.

Clinical trial NCT04595734 · UNKNOWN

Trial details

NCT number
NCT04595734
Sponsor
Western Sydney Local Health District
Status
UNKNOWN
Study type
OBSERVATIONAL
Lung Cancer Stage IVLung Cancer, Non-small CellHepatitis
Start date
2020-01-07
Primary completion
2023-01-10
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.